- Home
- GDTC vs PLUR Comparison
GDTC vs PLUR Comparison
Compare GDTC & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- PLUR
- Stock Information
- Founded
- GDTC 2018
- PLUR 2001
- Country
- GDTC Singapore
- PLUR Israel
- Employees
- GDTC N/A
- PLUR N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GDTC Health Care
- PLUR Health Care
- Exchange
- GDTC Nasdaq
- PLUR Nasdaq
- Market Cap
- GDTC 25.1M
- PLUR 27.9M
- IPO Year
- GDTC 2023
- PLUR N/A
- Fundamental
- Price
- GDTC $2.17
- PLUR $5.38
- Analyst Decision
- GDTC Buy
- PLUR
- Analyst Count
- GDTC 1
- PLUR 0
- Target Price
- GDTC $5.00
- PLUR N/A
- AVG Volume (30 Days)
- GDTC 22.4K
- PLUR 34.6K
- Earning Date
- GDTC 01-01-0001
- PLUR 11-12-2024
- Dividend Yield
- GDTC N/A
- PLUR N/A
- EPS Growth
- GDTC N/A
- PLUR N/A
- EPS
- GDTC N/A
- PLUR N/A
- Revenue
- GDTC $330,254.00
- PLUR $598,000.00
- Revenue This Year
- GDTC $14.71
- PLUR N/A
- Revenue Next Year
- GDTC N/A
- PLUR N/A
- P/E Ratio
- GDTC N/A
- PLUR N/A
- Revenue Growth
- GDTC N/A
- PLUR 135.43
- 52 Week Low
- GDTC $1.20
- PLUR $3.76
- 52 Week High
- GDTC $5.50
- PLUR $8.48
- Technical
- Relative Strength Index (RSI)
- GDTC 47.02
- PLUR 55.50
- Support Level
- GDTC $2.11
- PLUR $5.37
- Resistance Level
- GDTC $2.60
- PLUR $6.14
- Average True Range (ATR)
- GDTC 0.33
- PLUR 0.42
- MACD
- GDTC -0.07
- PLUR 0.13
- Stochastic Oscillator
- GDTC 34.42
- PLUR 58.92
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.